- Home
- CCCC vs OWLT Comparison
CCCC vs OWLT Comparison
Compare CCCC & OWLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCC
- OWLT
- Stock Information
- Founded
- CCCC 2015
- OWLT 2013
- Country
- CCCC United States
- OWLT United States
- Employees
- CCCC N/A
- OWLT N/A
- Industry
- CCCC Biotechnology: Pharmaceutical Preparations
- OWLT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CCCC Health Care
- OWLT Health Care
- Exchange
- CCCC Nasdaq
- OWLT Nasdaq
- Market Cap
- CCCC 104.4M
- OWLT 98.3M
- IPO Year
- CCCC 2020
- OWLT N/A
- Fundamental
- Price
- CCCC $2.50
- OWLT $9.30
- Analyst Decision
- CCCC Buy
- OWLT
- Analyst Count
- CCCC 2
- OWLT 0
- Target Price
- CCCC $8.00
- OWLT N/A
- AVG Volume (30 Days)
- CCCC 1.8M
- OWLT 88.3K
- Earning Date
- CCCC 08-07-2025
- OWLT 08-07-2025
- Dividend Yield
- CCCC N/A
- OWLT N/A
- EPS Growth
- CCCC N/A
- OWLT N/A
- EPS
- CCCC N/A
- OWLT N/A
- Revenue
- CCCC $34,240,000.00
- OWLT $89,856,000.00
- Revenue This Year
- CCCC N/A
- OWLT $21.93
- Revenue Next Year
- CCCC N/A
- OWLT $22.54
- P/E Ratio
- CCCC N/A
- OWLT N/A
- Revenue Growth
- CCCC 16.55
- OWLT 36.90
- 52 Week Low
- CCCC $1.09
- OWLT $2.75
- 52 Week High
- CCCC $7.22
- OWLT $10.30
- Technical
- Relative Strength Index (RSI)
- CCCC 62.57
- OWLT 63.98
- Support Level
- CCCC $1.95
- OWLT $6.21
- Resistance Level
- CCCC $2.35
- OWLT $7.94
- Average True Range (ATR)
- CCCC 0.24
- OWLT 0.84
- MACD
- CCCC 0.00
- OWLT -0.02
- Stochastic Oscillator
- CCCC 55.56
- OWLT 75.58
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.
About OWLT Owlet Inc.
Owlet Inc is engaged in providing a digital parenting platform that aims to give parents real-time data and insights to help parents feel more calm and confident. Its diversified portfolio of products includes Owlet Smart Sock, the first baby monitor to track an infant's oxygen levels, heart rate, and sleep trends; the Owlet Cam, which turns any smartphone into a baby monitor with high-definition clarity; the Owlet Monitor Duo, which offers the intelligence of the Owlet Smart Sock paired with the Owlet Cam; and Owlet Dream Lab, an interactive online program designed to be a parent's guide to building healthy sleep habits for their infants.